Incyte (INCY) Misses Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $125.31 -1.81%
EPS Growth %: -225.2%
Financial Fact:
Total costs and expenses: 247.18M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -225.2%
Financial Fact:
Total costs and expenses: 247.18M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q4 EPS of $1.06, $0.08 worse than the analyst estimate of $1.14. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $1.01 billion.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald as Opzelura Attractive in HS
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Anthropic delays planned IPO from October to November - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
